Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05356741 |
|---|---|
| Brief Title: | To Access the Safety and Effects of Intravenous Administration of AMX-818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers |
| First Submitted : | April 26, 2022 |
| First Submitted that Met QC Criteria : | April 26, 2022 |
| First Posted : | May 2, 2022 |
| Last Update Submitted that Met QC Criteria : | March 6, 2024 |
| Last Update Posted : | March 8, 2024 |